Evolving treatment paradigms in recurrent and metastatic head and neck squamous cell carcinoma: the emergence of immunotherapy

被引：1
|
作者：
Faraji, Farhoud [1 ]
Cohen, Ezra E. W. [2 ]
Guo, Theresa W. [1 ]
机构：
[1] UC San Diego Hlth, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr, Dept Otolaryngol Head & Neck Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Dept Internal Med, Gleiberman Head & Neck Canc Ctr, Moores Canc Ctr,Div Hematol Oncol, La Jolla, CA USA
来源：
TRANSLATIONAL CANCER RESEARCH | 2023年 / 12卷 / 05期
关键词：
Immunotherapy; salvage surgery; head and neck squamous cell carcinoma (HNSCC); HUMAN-PAPILLOMAVIRUS; INVESTIGATORS CHOICE; COMORBIDITY INDEX; MUTATIONAL BURDEN; SURGICAL SALVAGE; PD-1; BLOCKADE; CHECKMATE; 141; OPEN-LABEL; SURVIVAL; CANCER;
D O I：
10.21037/tcr-23-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1353 / 1358
页数：6
相关论文
共 50 条
  • [31] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [32] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
  • [33] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [34] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, H-F.
    Hong, R-L.
    ANNALS OF ONCOLOGY, 2018, 29 : 379 - 379
  • [35] Chemotherapy postimmunotherapy for recurrent metastatic head and neck squamous cell carcinoma
    Ducoulombier, Agnes
    Guigay, Joel
    Etienne-Grimaldi, Marie-Christine
    Saada-Bouzid, Esma
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 166 - 177
  • [36] Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma
    Specenier, Pol
    Vermorken, Jan B.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (09) : 901 - 915
  • [37] Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma
    Hedberg, Matthew L.
    Goh, Gerald
    Chiosea, Simion I.
    Bauman, Julie E.
    Freilino, Maria L.
    Zeng, Yan
    Wang, Lin
    Diergaarde, Brenda B.
    Gooding, William E.
    Lui, Vivian W. Y.
    Herbst, Roy S.
    Lifton, Richard P.
    Grandis, Jennifer R.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (01): : 169 - 180
  • [38] Novel Systemic Treatment Modalities Including Immunotherapy and Molecular Targeted Therapy for Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
    Ghosh, Soma
    Shah, Pooja A.
    Johnson, Faye M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [39] Immunotherapy for head and neck squamous cell carcinoma
    Fuereder T.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 66 - 69
  • [40] Immunotherapy for head and neck squamous cell carcinoma
    Li, Qiao
    Prince, Mark E. P.
    Moyer, Jeffrey S.
    ORAL ONCOLOGY, 2015, 51 (04) : 299 - 304
12345